CYP2D6 and squamous cell carcinoma: One of which is the polymorphisms in CYP2D6 and CYP1A1 that have been studied in Egypt and Tunisia (321–323) and that of CYP2D*1A, which was found to increase the risk and clinicopathological outcome of both transitional and squamous cell carcinomas in Egypt (322).